Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Iatreia ; 2(2): 161-164, ago. 1989.
Article in Spanish | LILACS | ID: lil-84308

ABSTRACT

El sindrome neuroleptico maligno (SNM) es una complicacion rara, idiosincratica y potenciamente fatal, relacionanda con el uso de drogas que afectan el sistema dopaminergico; su cuadro clinico consiste en sintomas extrapiramidales, signos de disfuncion autonomica y trastornos en el estado de conciencia, asociados a leucocitosis y a cifras muy elevadas de creatinina fosioquinasa. Reportamos el caso de un hombre de 32 anos que preesento un sindrome catatonico severo despues del uso intrahospitalario de antipsicoticos potentes a altas dosis para el control de una depresion psicotica. Se discuten las caracteristicas clinicas del paciente y los hallazgos comunes en el SNM


The Neuroleptic Malignant Syndrome (NMS) Is a rare, idiosyncratic and potentially fatal complication of therapy with many drugs affecting the dopaminergic system; It Includes extrapyramidal symptoms, signs of autonomic dysfunction, disorders of consciousness, leucocytosis and an increase in serum creatine phosphokinase .We report the case of a 32 years old man, who developed a severe catatonic syndrome after receiving high doses of potent neuroleptics to control a psychotic depression. Clinical features of this case and common findings of NMS are discussed


Subject(s)
Humans , Male , Adult , Neuroleptic Malignant Syndrome , Colombia , Neuroleptic Malignant Syndrome/diagnosis , Neuroleptic Malignant Syndrome/therapy
SELECTION OF CITATIONS
SEARCH DETAIL